Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05833516 · ClinicalTrials.gov registry record
Hyper Adduction of Right Radial Artery/Arm vs Left Drag Over Technique
A clinical trial, sponsored by Maimonides Medical Center.
- Completed
- Registry status
- 534
- Enrollment target
NCT05833516: Completed study, sponsored by Maimonides Medical Center.
NCT05833516 is a clinical trial that has completed, run by Maimonides Medical Center. The registered enrollment target is 534 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05833516 has completed, sponsored by Maimonides Medical Center.
- COMPLETED
- Registry status
- 534 participants
- Enrollment target
Study Summary
Several studies have shown that operator exposure via left transradial catheterization has yielded less operator exposure compared to standard right transradial procedure. However, in light of new data, the investigators hypothesize a hyperadducted right arm during right transradial cardiac catheterization will yield comparable, or the same operator radiation exposure.
Primary Outcome
The primary operators will wear real time radiation dose monitoring at the left eye, right eye, thorax and abdomen level. At the end of each diagnostic procedure the cumulative radiation dose (measured in µSv) data at each level will be collected
Interventions
- DIAGNOSTIC_TEST Cardiac Catheterization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 534 participants |
| Start Date | 2022-11-10 |
| Est. Completion | 2024-02-23 |
What the finished NCT05833516 record still lists
NCT05833516 is an observational study that tracks outcomes without assigning an intervention. The registered 534 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Catheterization is the first listed.
NCT05833516 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05833516 about?
NCT05833516 is a clinical study titled "Hyper Adduction of Right Radial Artery/Arm vs Left Drag Over Technique". Several studies have shown that operator exposure via left transradial catheterization has yielded less operator exposure compared to standard right transradial procedure. However, in light of new data, the investigators hypothesize a hyperadducted right arm during right transradial cardiac catheter...
What is the current status of trial NCT05833516?
This trial is currently completed. The enrollment target is 534 participants. The study started on 2022-11-10. Estimated completion is 2024-02-23.
What interventions are being tested in trial NCT05833516?
The interventions under investigation include: Cardiac Catheterization (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05833516?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04910685 · 534 participants · Phase 2
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
- NCT06128551 · 534 participants · Phase 1
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NCT05614739 · 535 participants · Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- NCT07091617 · 535 participants · NA
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI